Peter J Malloy1, Velibor Tasic2, Doris Taha3, Filiz Tütüncüler4, Goh Siok Ying5, Loke Kah Yin5, Jining Wang1, David Feldman1. 1. Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA. 2. Department of Pediatric Nephrology, Clinic for Children's Diseases, University Children's Hospital, Medical School of Skopje, Skopje, Macedonia. 3. Department of Endocrinology, Children's Hospital of Michigan, Detroit, MI 48201, USA. 4. Pediatric Endocrinology, Trakya University, Faculty of Medicine, Edirne, Turkey. 5. Department of Pediatrics, University Children's Medical Institute, National University Hospital, Singapore.
Abstract
CONTEXT: Hereditary vitamin D resistant rickets (HVDRR), also known as vitamin D-dependent rickets type II, is an autosomal recessive disorder characterized by the early onset of rickets with hypocalcemia, secondary hyperparathyroidism and hypophosphatemia and is caused by mutations in the vitamin D receptor (VDR) gene. The human gene encoding the VDR is located on chromosome 12 and comprises eight coding exons and seven introns. OBJECTIVES, PATIENTS, AND METHODS: We analyzed the VDR gene of 5 previously unreported patients, two from Singapore and one each from Macedonia (former Yugoslav Republic), Saudi Arabia and Turkey. Each patient had clinical and radiographic features of rickets, hypocalcemia, and the 4 cases that had the measurement showed elevated serum concentrations of 1,25-dihydroxyvitamin D (1,25(OH)(2)D). Mutations were re-created in the WT VDR cDNA and examined for 1,25(OH)(2)D(3)-mediated transactivation in COS-7 monkey kidney cells. RESULTS: Direct sequencing identified four novel mutations and two previously described mutations in the VDR gene. The novel mutations included a missense mutation in exon 3 causing the amino acid change C60W; a missense mutation in exon 4 causing the amino acid change D144N; a missense mutation in exon 7 causing the amino acid change N276Y; and a 2bp deletion in exon 3 5'-splice site (IVS3∆+4-5) leading to a premature stop. CONCLUSIONS: These 4 unique mutations add to the previous 45 mutations identified in the VDR gene in patients with HVDRR.
CONTEXT: Hereditary vitamin D resistant rickets (HVDRR), also known as vitamin D-dependent rickets type II, is an autosomal recessive disorder characterized by the early onset of rickets with hypocalcemia, secondary hyperparathyroidism and hypophosphatemia and is caused by mutations in the vitamin D receptor (VDR) gene. The human gene encoding the VDR is located on chromosome 12 and comprises eight coding exons and seven introns. OBJECTIVES, PATIENTS, AND METHODS: We analyzed the VDR gene of 5 previously unreported patients, two from Singapore and one each from Macedonia (former Yugoslav Republic), Saudi Arabia and Turkey. Each patient had clinical and radiographic features of rickets, hypocalcemia, and the 4 cases that had the measurement showed elevated serum concentrations of 1,25-dihydroxyvitamin D (1,25(OH)(2)D). Mutations were re-created in the WT VDR cDNA and examined for 1,25(OH)(2)D(3)-mediated transactivation in COS-7 monkey kidney cells. RESULTS: Direct sequencing identified four novel mutations and two previously described mutations in the VDR gene. The novel mutations included a missense mutation in exon 3 causing the amino acid change C60W; a missense mutation in exon 4 causing the amino acid change D144N; a missense mutation in exon 7 causing the amino acid change N276Y; and a 2bp deletion in exon 3 5'-splice site (IVS3∆+4-5) leading to a premature stop. CONCLUSIONS: These 4 unique mutations add to the previous 45 mutations identified in the VDR gene in patients with HVDRR.
Authors: J Miller; K Djabali; T Chen; Y Liu; M Ioffreda; S Lyle; A M Christiano; M Holick; G Cotsarelis Journal: J Invest Dermatol Date: 2001-09 Impact factor: 8.551
Authors: Peter J Malloy; Rong Xu; Lihong Peng; Sara Peleg; Abdullah Al-Ashwal; David Feldman Journal: Endocrinology Date: 2004-08-12 Impact factor: 4.736
Authors: T M Nguyen; P Adiceam; M L Kottler; H Guillozo; M Rizk-Rabin; F Brouillard; P Lagier; C Palix; J M Garnier; M Garabedian Journal: J Bone Miner Res Date: 2002-09 Impact factor: 6.741
Authors: Daniel J Saltzberg; Howard B Broughton; Riccardo Pellarin; Michael J Chalmers; Alfonso Espada; Jeffrey A Dodge; Bruce D Pascal; Patrick R Griffin; Christine Humblet; Andrej Sali Journal: J Phys Chem B Date: 2016-12-01 Impact factor: 2.991
Authors: Seong Min Lee; Kathleen A Bishop; Joseph J Goellner; Charles A O'Brien; J Wesley Pike Journal: Endocrinology Date: 2014-04-02 Impact factor: 4.736
Authors: J Wesley Pike; Mark B Meyer; Nancy A Benkusky; Seong Min Lee; Hillary St John; Alex Carlson; Melda Onal; Sohel Shamsuzzaman Journal: Vitam Horm Date: 2015-11-27 Impact factor: 3.421
Authors: Eric T Rush; Britt Johnson; Swaroop Aradhya; Daniel Beltran; Sara L Bristow; Scott Eisenbeis; Norma E Guerra; Stan Krolczyk; Nicole Miller; Ana Morales; Prameela Ramesan; Soodabeh Sarafrazi; Rebecca Truty; Kathryn Dahir Journal: J Bone Miner Res Date: 2021-11-10 Impact factor: 6.390
Authors: Qianqian Pang; Xuan Qi; Yan Jiang; Ou Wang; Mei Li; Xiaoping Xing; Jin Dong; Weibo Xia Journal: Bone Res Date: 2016-06-21 Impact factor: 13.567
Authors: Fatima A H Al-Jaberi; Martin Kongsbak-Wismann; Alejandro Aguayo-Orozco; Nicolai Krogh; Terkild B Buus; Daniel V Lopez; Anna K O Rode; Eva Gravesen; Klaus Olgaard; Søren Brunak; Anders Woetmann; Niels Ødum; Charlotte M Bonefeld; Carsten Geisler Journal: Front Immunol Date: 2021-05-19 Impact factor: 7.561